ClinicalTrials.gg

Program

TSND-201

A development code.

Its studies are mostly in Stress Disorders, Post-Traumatic, led by Otsuka.

Furthest: phase 3, since Mar 2, 20263 company-led studies, 3 open or runningNext primary completion: Dec 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Otsuka33 open or runningphase 3since Mar 2, 2026Mar 2, 2026Dec 2027phase 3 · NCT07456696

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 2, 2026First study: phase 3 study in Stress Disorders, Post-TraumaticFirst studyNCT07456696 · 300 planned · United States
  2. Jun 19, 2026Phase 3 study in Stress Disorders, Post-TraumaticNCT07670702 · 300 planned · United States
  3. Sep 17, 2026Phase 3 study in Stress Disorders, Post-TraumaticNCT07836647 · 300 planned · United States

Ahead

  1. Dec 2027Primary completion: phase 3 study in Stress Disorders, Post-TraumaticNCT07456696
  2. Feb 2028Primary completion: phase 3 study in Stress Disorders, Post-TraumaticNCT07836647
  3. Dec 2028Primary completion: phase 3 study in Stress Disorders, Post-TraumaticNCT07670702

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07836647Stress Disorders, Post-Traumatic · United States3RecruitingFeb 2028300
NCT07670702Stress Disorders, Post-Traumatic · United States3By invitationDec 2028300
NCT07456696Stress Disorders, Post-Traumatic · United States3RecruitingDec 2027300

How it is read

Names in the registry

  • “TSND-201”, 3 entries

Codes read as this program: TSND201.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.